CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan, the rest of Asia, and Europe. It operates through Regenerative Medicine Support Business and Cell Sheet Regenerative Medicine Business segments. The company is involved in commercializing regenerative medicine using cell sheets, which include autologous and allogeneic chondrocyte sheets. It also offers regenerative medicine contract services comprising contract development and manufacturing; contract manufacturing and consulting for specified cell-based products; and training and education in cell culturing technology services. In addition, the company provides UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell, a temperature-responsive cell cultureware for cell collection; HydroCell, a low cell binding cultureware; ThermoPlate III, a heating element made of a transparent glass plate; cellZscope, an automated cell monitoring system; and cell sheet support products. CellSeed Inc. was incorporated in 2001 and is headquartered in Koto, Japan.
Frequently asked questions
What sector does CellSeed Inc (7776) operate in?
CellSeed Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is CellSeed Inc (7776) current stock price?
As of the latest data, CellSeed Inc stock price is ¥226, with a previous close of ¥226.
What is CellSeed Inc (7776) current market capitalization?
CellSeed Inc market cap is approximately 8.91 billion.
What is CellSeed Inc (7776) Earnings Per Share (EPS)?
The trailing EPS is -¥29.
What is CellSeed Inc (7776) EBITDA?
CellSeed Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -320.63 million.
Does CellSeed Inc (7776) pay dividends?
No. CellSeed Inc does not pay a dividend.
What is CellSeed Inc (7776) beta (volatility) score?
CellSeed Inc has a beta of 1.201, suggesting it is more volatile than the market.
